Inspire
Innovate
Achieve Excellence
Our core innovation is based on a patented neuromorphic (bio-mimetic) algorithm , HOTS (Hierarchy Of event-based Time-Surfaces), that detects and predicts deterioration in state of health of patients and alerts care givers to allow earlier intervention and avoid costly hospitalizations.
Chronolife has also developed a patented smart t-shirt capable of capturing 6 different physiological parameters paving the way for continuous remote monitoring through easy to use everyday garment.
Our vision:
To be at the fore front of developing highly innovative digital health solutions paired with predictive algorithm.
Our mission:
To enable healthcare professionals to have timely information for earlier intervention and to ensure a continuum of care that fills the existing gaps from hospital to home.
Laurent Vandebrouck
CEO of Chronolife
Before joining Chronolife, Laurent set up and grew Qualcomm Life in Europe between 2012 and 2018, Qualcomm Life being an enabler and connectivity provider for connected and Digital Health services globally.
Prior to Qualcomm Life, Laurent developed, launched and managed different new businesses and P&L for the enterprise market in B2B mode for leading satellite operators such as Eutelsat and for leading wireless communication technology providers such as Qualcomm.
His expertise is therefore focused on the development and operation of end-to-end services leveraging innovative satellite, cellular, IoT and Cloud based technologies applied to the enterprise market in general and to Digital Health in particular.
Team
-
-
-
Dr Birgit AssmusHead of Cardiology Department and of Interdisciplinary Center of Heart FailureGoethe University Frankfurt
Germany
-
-
-
-
-
-
-
-
-
Dr Marc SalomonCardiovascular & preventive medicineImpact Healthcare
128 rue La Boétie
75008 Paris
France -
-
Aline BertaudOffice Manager -
-
-
-
-
-
-
-
-
-
Ludovic RemondQuality & Production Specialist -
-
Dr Laurent Sebbag (Chair)Head of Heart Failure and Transplant DepartmentHopital Louis Pradel
59 Boulevard Pinel
69500 Bron
France -
Dr Peter Karl JacobsenDirector of Arrhythmia ServiceDepartment of Cardiology, The Heart Center, University of Copenhagen
Rigshospitalet, Blegdamsvej 9
2300 København Ø
Denmark -
Dr Kasper RossingDepartment of Cardiology, The Heart Center, University of CopenhagenRigshospitalet, Blegdamsvej 9
2300 København Ø
Denmark -
Dr Thierry DantoineHead of Geriatric MedicineCentre hospitalier universitaire de Limoges
2 Avenue Martin Luther King,
87000 Limoges
France -
Dr Fadi JamalCardiologistCARDIOPARC
155 Ter, Boulevard Stalingrad
69006 LYON
France -
Dr Marcel Garrigou-GrandchampGeneral Practitioner56 Rue Jeanne d'Arc
69003 Lyon
France -
Bernard GillyFounder & chairman of several successful disruptive biotech & medtech companies: Tilak Healthcare, Chronolife, Prophesee, Gecko Biomedical, GenSight Biologics , Pixium Vision, Enterome, Fovea Pharmaceuticals (acquired by Sanofi). Previously Managing Partner at Sofinnova Partners (Paris), Chairman & CEO of Transgene, VP R&D at BioMerieux. -
Alexia PerouseSuccessful lead/co-lead investor in 10+ innovative HealthTech start-ups, from Series A to exit. Head of Healthcare VC at Omnes Capital. Spin-off of Credit Agricole Private Equity in 2012 - € 330m AUM in venture capital. Active role as a member of the board of directors and committees (remco, audit, strategy). Involved in 8 M&A and IPOs, Investment Manager in Sofinnova Partners. -
Donald JonesDonald Jones serves as an independant board member for venture backed health companies and on Fortune 1000 Digital Health Advisory Boards. His expertise is in growing digital heath, digital therapeutics and technology enabled health services. He is globally recognized for his digital transformation expertise. -
Bruno CerveraBruno manages Passage de l’Innovation, startup studio of the iBionext ecosystem. He is specialized in administrative and financial time-share management with project leaders and innovative companies in the field of biotech/medtech. He is also specialized in IPO preparations and has participated in 6 IPOs. -
Adreapending
-
Dimitri BoulangerDimitri runs the single family office Celeste Management, based in Geneva, Switzerland. Celeste invests across multiple alternative asset classes in private equity, venture, infrastructure, real estate and private debt. Celeste has invested in several start ups especially in the health space. -
-
Denis FendtDenis Fendt is Vice President and Director of Development of the Aesio Group. Actuary by training, Denis has spent his entire career in the world of insurance. He held technical, financial and commercial positions in the AXA, Mercer and Swisslife groups before joining Aésio in November 2016.